Inicio > BIGG > Resultado de la búsqueda

    Resultados: 3

    ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update

    Baraliakos, Xenofon; Boteva, Boryana; Bremander, Ann; Carron, Philippe; Ciurea, Adrian; Hooge, Manouk de; van der Heijde, Désirée; Gensler, Lianne; van Gaalen, Floris A; Géher, Pál; Hermann, Josef; Husakova, Marketa; Kiltz, Uta; Landewé, Robert B M; López-Medina, Clementina; Machado, Pedro M; Marzo-Ortega, Helena; Molto, Anna; Navarro-Compán, Victoria; Nikiphorou, Elena; Nissen, Michael J; Ortolan, Augusta; Pimentel-Santos, Fernando M; Poddubnyy, Denis; Proft, Fabian; Ramiro, Sofia; Rudwaleit, Martin; Sepriano, Alexandre; Telkman, Mark; Van den Bosch, Filip E; Webers, Casper; Zhao, Sizheng Steven; Ziade, Nelly.
    Ann. rheum. dis; 82 (1), 2023
    To update the Assessment of SpondyloArthritis international Society (ASAS)-EULAR recommendations for the management of axial spondyloarthritis (axSpA). Following the EULAR Standardised Operating Procedures, two systematic literature reviews were conducted on non-pharmacological and pharmacological treatm...
    Espondiloartritis Axial/tratamiento farmacológico, Antirreumáticos/uso terapéutico, Manejo de Atención al Paciente/normas
    Texto completo

    Spondyloarthritis in over 16s: diagnosis and management

    England. National Institute for Health and Care Excellence.
    This guideline covers diagnosing and managing spondyloarthritis that is suspected or confirmed in adults who are 16 years or older. It aims to raise awareness of the features of spondyloarthritis and provide clear advice on what action to take when people with signs and symptoms first present in healthca...
    Espondiloartritis/prevención & control, Espondiloartritis/diagnóstico, Espondiloartritis/tratamiento farmacológico, Antirreumáticos/uso terapéutico, Inmunosupresores/uso terapéutico
    Texto completo

    2015 Recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative

    Dejaco, C; Singh, Y. P; Perel, P; Hutchings, A; Camellino, D; Mackie, S; Abril, A; Bachta, A; Balint, P; Barraclough, K; Bianconi, L; Buttgereit, F; Carsons, S; Ching, D; Cid, M; Cimmino, M; Diamantopoulos, A; Docken, W; Duftner, C; Fashanu, B; Gilbert, K; Hildreth, P; Hollywood, J; Jayne, D; Lima, M; Maharaj, A; Mallen, C; Martinez-Taboada, V; Maz, M; Merry, S; Miller, J; Mori, S; Neill, L; Nordborg, E; Nott, J; Padbury, H; Pease, C; Salvarani, C; Schirmer, M; Schmidt, W; Spiera, R; Tronnier, D; Wagner, A; Whitlock, M; Matteson, E. L; Dasgupta, B.
    Ann. rheum. dis; 74 (10), 2015
    Therapy for polymyalgia rheumatica (PMR) varies widely in clinical practice as international recommendations for PMR treatment are not currently available. In this paper, we report the 2015 European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) recommendations for the managemen...
    Polimialgia Reumática/tratamiento farmacológico, Antirreumáticos/uso terapéutico, Glucocorticoides/uso terapéutico, Factores de Riesgo, Enfoque GRADE
    Texto completo